Article -> Article Details

The expansion of the breast lesion localization global market can be attributed to the intervention of disruptive breast lesion localization technology and products. The increase in cases of breast cancer, both in females and males due to genetic and environmental factors, is creating the need for effective breast lesion localization solutions.

As per Market Research Future (MRFR) analysis of the Global Breast Lesion Localization Market 2020 across the analysis period 2019 to 2025, reveals forces that can impact the market. The breast lesion localization global market can rise at 6.8% CAGR across the analysis period. By 2025, the breast lesion localization market can earn USD 560 Million.

Regional Analysis

Americas, EU, APAC, following the Middle East, and Africa are regions across which the breast lesion market is studied. MRFR regional evaluation reveals that the breast lesion market in North America can expand at a high pace across the review period. North America breast lesion market can garner high revenue in the analysis period due to an increase in cases of breast cancers among men and women.

The development of breast lesion localization care departments across multiple hospitals can support the regional market across the review period. Latin America and South American can thrive across the analysis period due to an increase in cases.

The US and Canada can earn high profits for the regional market. In the EU, the prevalence of sedentary lifestyles and increase in the consumption of alcohol are some leading causes that are resulting in a surge in cases of cancer in the region.

The growing number of breast cancer across the review period can impact the expansion of breast lesion localization market across the review period. The introduction and adoption of new diagnostic products across multiple diagnostic centers can push the regional market in the years to come.

Non-essential healthcare procedures as well as surgeries had to be postponed as well, which is touted to leave a slightly negative impact on the global market. On the bright side, companies are working on leveraging the potential of artificial intelligence, IoT and big data by integrating these technologies into their product ranges, which will ensure sustained market growth in the ensuing period.

Market Segmentation

The segment assessment of the Breast Lesion Localization Global Market are based on Usage, Type, Technique, and End Users.

The type-based segment of the breast lesion localization global market are radioactive seed localization, wire-guided localization, magnetic seed, non-radioactive radar localization, and others. The wire-guided localization segment can generate considerable turnover for the breast lesion market the year ahead. This segment can hold the highest share of the worldwide market across the review period.

The magnetic seed segment is likely to be the rapidly growing segment in the analysis period. The technique based segments of the breast lesion localization global market are core needle biopsy, fine-needle aspiration biopsy, and image-guided biopsy.

The end-user based segment of the breast lesion market are ambulatory surgical centers, hospitals and clinics, and diagnostic centers.

Key Players

B.D. Company (US), Endomagnetics Ltd (UK), Cook Medical (US), Cianna Medical (US), Health Beacon (Ireland),  Somatex Medical Technologies GmbH (Germany), Surgiceye GmbH (Germany), Intramedicalimaging, Devicor Medical Products, Inc (US), and Ranfac Corporation (US) are some reputed names in the Breast Lesion Localization Market that are listed by MRFR.